vtx logo

request clinical advice

vtx logo sticky

Felipe M.

Forum Replies Created

Viewing 15 posts - 1 through 15 (of 95 total)
  • Author
    Posts
  • Felipe M.
    Moderator

    Replying to scott@vtx-cpd.com 25/07/2025 - 00:19

    Hi everyone
    Such an interesting piece of research.
    I have to say it reflects the vast majority of the patients I have treated over the years.
    Taking into account that the unobstruction and return of renal elimination of potassium is the most effective way of reducing the kalaemia, it makes sense to use calcium gluconate to keep things stable whilst progressing with the procedure. Additionally, intracellular shift of potassium could worsen the post obstruction diuresis-mediated potential hypokalaemia. So keeping kalaemia steady if possible seems sensible.
    I have to say however , that there might be a small cohort of patients where the ECG/CV effects of the kalaemia are so profound, or where the AKI caused results in no immediate diuresis after unobstruction, that calcium gluconate might not be enough or fast enough (although generally faster than glucose/insulin in my hands) or effective enough, and that therefore pharmacological intracellular shift of potassium might be needed for GA to be tolerated. This I feel it’s reflected in the “most of” part of the conclusion. However I have to say for the vast majority of patients I have treated, the treatment described is what is needed to progress. Rapid unobstruction, but always ensuring/once the animal is in a position to tolerate anaesthesia, is the best approach.
    Great stuff
    Felipe

    Felipe M.
    Moderator

    Hi Jo

    It’s fantastic to hear you are enjoying your experience. Hospital settings can be lots of fun.

    Great question, and one that does not have a straightforward answer.

    The reality is we do not have much evidence in terms of the effects of SQ or IM single doses of ketamine for pain relief. SQ pulse ketamine therapy is a fairly popular choice, where the patient gets an injection of around 0.5mg/kg SQ every so often (it can be days, weeks or even months) as part of a chronic pain plan. It would be wishful to think the ketamine hangs around for such a long time to help our patients, as realistically it will be gone in no more than a couple of hours. What we hypothesise is that the transient effect in down-regulating the wind-up part of chronic pain (through NMDA receptor antagonism) helps get control of pain, yielding relief for some time (until the wind-up gets set in again). I do use it regularly and find it works, as so do many colleagues. However there are no studies on this. It would be very difficult to replicate in an uniform and reliable way to get trustworthy results. When we are in need of proper control of chronic pain though, a ketamine infusion for some hours, or even days, is definitely the way to go. Hope you find this useful!

    Interestingly, there is a paper which documents the absorption and pharmacokinetics of SQ ketamine (albeit delivered constantly through an insulin pump) in dogs (DOI https://doi.org/10.1111/jvp.13440) and another one in the positive effects of SQ ketamine given on postoperative pain in humans (DOI https://doi.org/10.1007/s12630-017-0914-0).

    Great topic

    Felipe

    Felipe M.
    Moderator

    Hi there

    Very interesting case, and fairly complex.I would approach it trying to find the best combination of drugs as well as management strategies that fit all the disease processes, by discerning the effect of those in the aptitude of the animal for coping.

    In terms of the PSS, being controlled is already a great start. However given the limited metabolism of drugs, these may have longer duration. For this reason I would choose short acting and if possible, antagonisable molecules. Unfortunately, everything is metabolised in the liver.

    Being a controlled diabetic is also a great place to start, so I would try to keep things as controlled as possible. If at all possible, a small wet food breakfast with 1/2 of insulin (I would in cases with no PSS give 1/2 to full dose, but given the PSS I would assume lower glycogen stores), planning the sedation for lunch time, so that we do not affect the balance, would be best. Alpha-2 agonists do inhibit the secretion of endogenous insulin, but since there is none to be secreted, there is nothing to lose. If a morning procedure is a must, then short fasting (4h) with a last meal comprised of wet food, and an insulin dose in the morning according to a blood glucose (I wold go 1/4 dose unless glucose is fairly high, I know this is subjective but I put things into context of what the normal values for the animal are. In animals without a PSS I would even go 1/2 dose). Glycaemia monitoring every 15m during sedation.

    Due to the OA, a good analgesia to help with worsening of pain due to positioning would help a lot.

    The pulmonary fibrosis is one of the key points here. Decreased compliance and increased recoil, which can cause respiratory fatigue and failure much more easily than in the healthy patient, especially if the respiratory function is affected by drugs. Oxygen supplementation and sternal recumbency as much as possible, or with breaks to give a minute or two in sternal if lateral recumbency is required, would be very advisable to prevent lung collapse. The use of alfaxalone for subanaesthetic effects would not be my choice as it will depress the respiratory drive much more, proportionally. Avoiding general anaesthesia where possible, and maintaining as light depth of sedation as feasible, would be also advantageous. Alpha-2 agonists will not change the pulmonary vascular pressures, so will not affect the PH.

    With all this in hand, I would probably choose methadone 0.2-0.3mg/kg IV (which I could antagonise with naloxone) and dexmedetomidine 3mcg/kg diluted in 6mL of saline and given slow IV to effect, 1mL at a time, assessing the response. Procedure scheduled for 13-14h procedure after light wet food breakfast with 1/2 to full caninsulin dose (Depending on what the glycaemia usually is for the animal) and glycaemia monitoring q15m during sedation. Wet food offered as soon as safe to do so. Oxygen supplementation, positioning control as above, and temperature maintenance. If antagonists are needed, naloxon and atipamezole as required.

    Hope this is helpful and that all goes well!

    Thanks

    Felipe

    Felipe M.
    Moderator

    Hello everyone
    Hope you all are doing great.
    I’d like to take the chance to join Scott in thanking everyone for choosing Vtx and myself for this journey.
    Anaesthesia, like many other disciplines, includes different techniques as well as the management of many different types of patients. In this course I have tried to put together some of the hottest topics I am frequently asked about, which build up on the basic principles of anaesthesia but go beyond them. Although these are more advanced concepts, I will still maintain a solid grounding with all the foundations which now become ever so important.
    At the end of every section I will upload a video as a form of catch up, where I will reflect on some of the concepts explored or expand on them.
    It is frankly very difficult to include every aspect of anaesthesia, and thus I have tried to include the ones I considered most helpful for everyone, but please do feel free to ask away in the forum if there is something you would like me to comment, or if you need some clarification on any concepts.
    I sincerely hope you find this course helpful and that you enjoy it as much as I enjoyed producing it.
    Very excited to start this journey with you all!
    Felipe

    Felipe M.
    Moderator

    Hello there everyone!

    My name is Felipe, and I will be speaking about the anaesthesia particulars of these challenging patients. First of all, thank you foe choosing us and being here for this exciting journey. I hope you find the course interesting and applicable to your everyday practice.

    Respiratory physiology is indeed complex, and disturbances in its effectiveness to carry out the many functions it serves has a big impact in patient safety and the tolerability of anaesthesia. We will also explore how decision making on our side plays a key role, sometimes with little time to make a clinical judgement.

    Really hope you enjoy this course, and please feel free to fire away any questions.

    Fantastic stuff!

    Felipe

    Felipe M.
    Moderator

    Hi Scott (and delegate!)

    What a fantastic question.

    Well done to our delegate, the approach is already very sensible indeed. However I cannot refrain from taking the chance to chip in to a couple of concepts.

    When wanting to avoid or decrease the dose of sedatives to avoid their side effects, using higher doses of opioids is a great option. I would go as high as 0.5mg/kg butorphanol/methadone, or start with a similar 0.3mg/kg dose and top up at any given time with 0.1mg/kg up to twice, to deepen the sedation.

    I will many times introduce some acepromazine at low doses (5-10mcg/kg) 20 min before the opiod to have some background sedation and additive/drug sparing effects. Obviously we don’t want to go much higher as lowering the blood pressure too much with a long-lasting agent in a hypertensive patient with an up-regulated organ perfusion auto-regulation is not desirable either.

    There is some value in having a very dilute low dose of medetomidine/dexmedetomidine (1-2mcg/kg in 5-10mL of saline) and administering over 5-10 minutes to get sedation with much less pronounced vasoconstriction. This is very much case and blood pressure values dependent, but in the cases where the animal is fit for them, the quality of the sedation is better than in any other combination. Introducing a benzodiazepine with this technique, to spare the dose given is a very good way forward too, more on that below!

    Using alfaxalone (or propofol) at subanaesthetic doses to achieve a sedation can be very helpful in these scenarios, but caution must be exercised as anaesthesia can be induced inadvertently and airway compromise may happen (due to obstruction, hypoventilation or aspiration). I would say that personally I find these drugs, compared to alpha-2 agonists at equivalent sedation levels, cause more respiratory depression and loss of airway protective reflexes, which I am not a fan of. I always recommend to have means to intubate and ventilate at the ready next to any sedated animal, much more so if these drugs are used.

    Introducing a benzodiazepine (especially after a low dose of alfaxalone/propofol, so as to avoid hyperexcitability) can be very helpful to deepen the sedation with less side effects than if we continued with the anaesthetic agent. I do this many times in cats (or even in cases where I used opioid and some alpha-2 agonist, to spare the alpha-2 agonist dose) and usually it works great. I have to say I personally do not do this in dogs as often, given they are more prone to hyperexcitability and even display of aggressive behaviour.

    In some cases I do use more complex combinations to spare drug dosing and side effects. As an example, I may start with 5mcg/kg acepromazine 20 minutes before the rest, then give butorphanol, then a very dilute alpha-2 agonist, and when I do not want to go any higher with alpha-2 agonists, deepen with alfaxalone or midazolam (or even both) at lower doses.

    Hope this helps! Please let me know if you would like me to elaborate further.

    Felipe

    Felipe M.
    Moderator

    Hello everyone

    Here we are now, at the end of the course! I want to send a massive thank you to everyone for having chosen Vtx and myself for this journey. Anaesthesia (like any other discipline) is indeed vast, and difficult to fit in a course, however I hope you have found here building blocks to make its practice safer, easier, and more enjoyable for your patients and yourselves. If you now like anaesthesia even if just a tiny bit more, I feel accomplished!
    You may feel now you want to introduce changes, and you may also find hurdles along the way when doing so. Changes can be difficult to navigate, especially in teams with different levels of training and confidence. Introduce one change at a time, choose the right patient, and make sure everybody reflects afterwards on how it went. Communication is key in our profession, and fundamental to teamwork.

    Once again, thank you.

    Take care, and look after yourselves.

    Felipe

    Felipe M.
    Moderator

    Replying to Bethany Deadman 09/03/2025 - 16:34

    Hi Bethany

    Pregabalin is regarded as a bit more predictable in its effects in humans, requiring less titration to reach a reliable clinical effect. The pharmacodynamics are quite complex because it does not work only on calcium channels, but in several other receptors, which makes it appear more advantageous. This article supports the pharmacokinetics in dogs: 10.1111/j.1467-2995.2009.00486.x

    In terms of NMDA antagonists, I do use them a lot in OA or any other type of sensitisation, including visceral. At the end of the day, what we are targeting is the open and working NMDA receptor in the dorsal horn of the spinal cord, which is causing the second order neuron to depolarise more easily. I do introduce them quite early in OA, even if in pulse therapy, if NSAIDs on their own do not yield all the effects I want. It’s the same principle as giving SQ ketamine every now and then, since ketamine, amantadine and memantine work in similar ways. Amantadine did have a restriction to its use in EU due to more astringent antiviral prescription guidelines, but we did not seem to get it in UK. However, I tend to prescribe even more frequently memantine, which is another molecule that works in the same NMDA receptor, but to my knowledge not regarded as an antiviral and still fine to be dispensed in EU countries under their equivalent to the cascade.

    Felipe

    Felipe M.
    Moderator

    Hi Bethany

    Thanks a lot for your kind words! So glad to hear you found the session and course helpful!

    Lidocaine and bupivacaine line blocks can certainly help a lot for a very small investment in time and resources, which in some cases like obstetrics, offers a clear benefit in my opinion.

    In cats I am certainly more careful with doses as their glucuroconjugation will limit metabolism. For bupivacaine I stay at 1mg/kg, and for lidocaine at 4mg/kg.

    With local anaesthetics, the lower the concentration, the less deep the nerve block (which in drugs like bupivacaine allows us to do ambulatory blocks and spare the motor fibres) and the shorter the duration of the block.

    Lidocaine can be diluted to 1% at a maximum, as I find any more dilution causes it to not work very reliable and not last long enough.

    Bupivacaine works down to a dilution of 0.125%, which is what we use for ambulatory blocks.

    As above, the lower the concentration, the higher likelihood of having some stimulus transmission. In limb or neuraxial blocks sparing the motor function many times is advantageous, but of a line block in an abdomen I dilute as little as I can just to have enough volume to cover the area.

    Hope it makes sense!

    Felipe

    Felipe M.
    Moderator

    Replying to Bethany Deadman 02/03/2025 - 17:17

    Hi Bethany (and Scott)

    I agree, there is a big challenge in many cases when transitioning from an in-patient to out-patient pain management. Without any doubt.

    I tend to rely a lot on gabapentin too. Although primarily used for neuropathic pain, there are reports of its use even in acute pain cases (the one that comes to mind, in a cat) with a very good result. I many times use gabapentin in a multimodal approach as soon as the animal allows tablets, to de-escalate the parenteral medication. Pregabalin is a drug I use nowadays even more than gabapentin, with superior analgesia effects in dogs due to higher bioavailability. It can cause also more sedation at times, so evaluating the effect in each patient will direct me towards changing to gabapentin in some cases.

    But obviously, gabapentin/pregabalin is not the cure for everything! and many animals need stronger analgesia.

    I agree with Scott, if I am against paracetamol, I will stay away from NSAIDs as well for the reasons he has nicely stated.

    Another one to use, especially if there is visceral sensitisation (or any other type of sensitisation), or somatic pain, is amantadine/memantine, which are also a good option within the multimodal approach.

    Although always keeping a healthy amount of skepticism due to its very large interindividual variability in effects, I do consider trialing oral tramadol as it will work in some animals. If I need more reliable analgesia than this, I will then move on to oral-transmucosal buprenorphine. This has been proven to work both in dogs and cats.

    If things are beyond this, I would re-consider keeping the animal as in-patient. If the animal must be discharged but is beyond the above, a fentanyl patch (ensuring the owners are also good candidates for this) can yield very good results too, with only visits needed every 3 days.

    Hope this helps!

    Felipe

    Felipe M.
    Moderator

    Replying to Raquel M. 24/02/2025 - 16:45

    Hi Raquel

    Hope you are well.

    Scott has already illustrated this amazingly, so just adding my own usual dosing and reasoning.

    As Scott has said, it all depends on the type and severity of pain. We do not have enough research, in my opinion, on enough pain levels and types. In humans there is, which is reflected in the wide therapeutic range. In a veterinary study of acute pain, a dose of 15mg/kg IV showed non-inferiority to a NSAID (with the limitations of the comparison in any case), so I tend to go for 15mg/kg TID IV. For oral administration, results are variable, but it seems doses of 25mg/kg PO were found effective. For this reason I tend to go with the licensed Pardale V dose of 33mg/kg PO TID up to 5 days, reducing to 20-25mg/kg if I need to use it for longer.
    Chronic cases are different as we are aiming at lowest doses effective (which at the end of the day are individual dependent) to avoid overloading the liver in the long term.

    Felipe

    Felipe M.
    Moderator

    Hi Bethany

    First of all, it seems you did already a fantastic job, well done!

    Hypoalbuminaemia can make things certainly tricky. In first place it will make a higher free fraction of the drug to be present due to lower binding capacity (albumin for neutral and acid drugs, alpha 1 glycoprotein for bases, such as local anaesthetics). Additionally the lower COP and glycocalyx disturbance will cause adverse fluid shifts and make patients more likely to become hypotensive. Lastly, acid-base status can be affected by hypoproteinaemia (reflected in the Atot in Stewart’s approach).

    So, with all this in hand it seems it was a great idea to infuse some albumin beforehand, even if the net effect wasn’t so impressive in the end. At that low level of serum proteins I would have done the same, more for the COP/glycocalyx than for the altered pharmacokinetics, which I can otherwise adjust the dosing for.

    In terms of the dosing, I find difficult to set standardised values for dosing indexed for the protein levels. This is so because the drugs commonly used in anaesthesia have a quite wide therapeutic window, and thus many times (but certainly not always) we won’t see dramatically different effects from administering 50% to even 100% more free fraction. In the case of induction agents, they are dosed to effect so we more or less bypass the problem. Even so, I tend to estimate the percentage decrease of albumin from the normal serum levels, and decrease my doses by roughly the same. In your case, given albumin was around half the normal levels, I would have gone with 0.1mg/kg of both butorphanol and midazolam. However, you can see things went very smoothly for you, so clearly what I wrote above applies in many cases.

    Administering FFP as a fluid was also a great choice to not dilute COP further and promote IV compartment retention of fluids. Certainly better than synthetic colloids!!! (dare I say their name…)

    Noradrenaline would probably have been my plan B too, if the heart rate had been on the higher side (more likely than not), there was no response to fluids and there was no other contraindications.

    Very complex cases with several potential complications!

    Hope this is of help, but let me know if you need further information.

    Felipe

    Felipe M.
    Moderator

    Replying to Bethany Deadman 23/02/2025 - 15:30

    Hi Bethany

    No problem at all!

    A PIVA technique would involve an intravenous infusion of drugs like fentanyl or dexmedetomidine, which would allow us to decrease our inhalant needs by about 20-40%, reducing its side effects too.

    I would use either or, or both, depending on what I need to achieve.

    I would use fentanyl if going for a surgical procedure and not having a locoregional technique on board, since it will add to the analgesia. I would also go for fentanyl if alpha-2 agonists are contraindicated (for example if younger than 12 weeks in age). However fentanyl does yield less potent MAC sparing effect at normal clinical doses.

    I would use dexmedetomidine if wanting to preserve vasomotor tone (to hopefully prevent some of the vasodilation), and needing a more potent MAC sparing effect and a more stable anaesthetic.

    Many times, if I could not perform a loco-regional technique for PSS surgery (rarely), I will go with both for added stability. Most of the times though, I do a dexmedetomidine PIVA and a loco-regional technique (QL block most frequently), and only add a fentanyl infusion if needing more analgesia or MAC sparing.

    Hope this helps!

    Felipe

    Felipe M.
    Moderator

    Hi Bethany

    Great question!

    Unfortunately all the information we have so far from SQ ketamine is anecdotal. I do agree it does seem to work in many animals, yielding an improvement in comfort levels sometimes for weeks.
    Pharmacokinetically the most probable way things work is that ketamine is absorbed, metabolised and excreted within a couple of hours at a maximum, however parmacodynamically, having exerted its action on the NMDA receptors does help in “resetting” to some extent the ascending pain pathways at the time, and helps other drugs be more effective. This causes a clinical effect that can be seen for weeks sometimes, but I would say caused by a short term pharmacological effect. I typically use 0.5-1mg/kg SQ.

    Unfortunately a SQ dose of ketamine cannot substitute an infusion. Using a ketamine infusion will always yield more profound effects, and actually having the patients on the infusion for 24-48h will have more chances at resetting the biochemical wind up than only doing so for 4-6h. So depending on the severity of the condition I will choose from a SQ injection as an add-on, an infusion for a couple of hours, or a protracted therapy for 1-2 days.

    Hope this helps!

    Felipe

    Felipe M.
    Moderator

    Hi Bethany
    You are very welcome, this is a great topic.
    Thank you Scott for pinning here the conversation we had regarding paracetamol in liver disease. As you can read there Bethany, I do have a bit of a defensive approach to the use of paracetamol on the basis of the licensing and the potential liability, which makes me try to avoid it in any scenario under “liver disease”. But I completely agree that a cholestatic pattern means nothing in terms of liver metabolism, and that it should not suggest non-competency of the animal to cope with paracetamol therapy. However, if there is a suitable alternative, and there usually is for me, I go with something else. This is my reasoning, but not necessarily the only way forward!

    In the animals I use paracetamol, I tend to go 15mg/kg IV TID or for oral follow Pardale V’s SPC and do 30-33mg/kg PO TID for up to 5 days. If I need to prescribe it for longer, I then decrease this dose to 15-25mg/kg PO BID-TID and consider liver monitoring if necessary.

    Hope this helps!

    Felipe

Viewing 15 posts - 1 through 15 (of 95 total)